You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV vaccine

Showing 1 - 25 of 9,138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Papillomavirus Vaccines Trial (Tailored text messages, Standard text messages)

Not yet recruiting
  • Human Papillomavirus Vaccines
  • Tailored text messages
  • Standard text messages
  • (no location specified)
Aug 12, 2023

HPV Vaccine on Menstrual Cycle in Women of Reproductive Age

Not yet recruiting
  • Menstrual Disorder
  • Premature Ovarian Failure
  • prophylactic HPV vaccine(bivalent HPV、quadrivalent HPV、9-valent HPV)
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cente
Apr 20, 2023

HPV Trial in Johannesburg (HPV Vaccine Communication Strategy)

Not yet recruiting
  • HPV
  • HPV Vaccine Communication Strategy
  • Johannesburg, Gautang, South Africa
    University of Witwatersrand Health Consortium
Jun 18, 2023

STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012

Completed
  • HPV
  • HPV-Related Cervical Carcinoma
  • HPV Vaccine Acceptance Survey
  • (no location specified)
Mar 1, 2023

Oropharyngeal Squamous Cell Carcinoma (SCC) Trial run by the National Cancer Institute (NCI) (PRGN-2009, Pembrolizumab)

Not yet recruiting
  • Oropharyngeal Squamous Cell Carcinoma (SCC)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 22, 2023

Cervical Cancer, Anal Cancer, Penile Cancer Trial in College Park (Personalized Chatbot Intervention, Non-Personalized Chatbot

Recruiting
  • Cervical Cancer
  • +2 more
  • Personalized Chatbot Intervention
  • +2 more
  • College Park, Maryland
    University of Maryland, College Park (Online Survey-Experiment)
Jul 17, 2023

Human Papillomavirus Infection, Vaccination Hesitancy Trial in Charlottesville (PSA Development, HPV vaccination focused social

Recruiting
  • Human Papillomavirus Infection
  • Vaccination Hesitancy
  • PSA Development
  • HPV vaccination focused social marketing campaign
  • Charlottesville, Virginia
    University of Virginia
May 5, 2023

Two Domestic HPV Vaccines and Imported HPV Vaccines in Women

Not yet recruiting
  • HPV Infection
  • +2 more
  • Follow up
  • Fuzhou, Fujian, China
    Fujian Maternity and Child Health Hospital
Nov 16, 2023

Immunization, HPV Infection, Human Papillomavirus Trial in Galveston (9-valent HPV vaccine, 2 doses alternate timing, 9-valent

Recruiting
  • Immunization
  • +2 more
  • 9-valent HPV vaccine, 2 doses alternate timing
  • 9-valent HPV vaccine, 3 doses standard timing
  • Galveston, Texas
    University of Texas Medical Branch
Jan 30, 2023

Human Papilloma Virus (HPV) Vaccine Trial in Tampa (HPV MISTICS -Provider Level, HPV MISTICS - Parent Level, HPV MISTICS- HPV

Recruiting
  • Human Papilloma Virus (HPV) Vaccine
  • HPV MISTICS -Provider Level
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 9, 2023

Human Papilloma Virus Infection Trial (9-valent HPV vaccine)

Not yet recruiting
  • Human Papilloma Virus Infection
  • 9-valent HPV vaccine
  • (no location specified)
Jul 11, 2022

High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle

Terminated
  • High Grade Anal Canal Intraepithelial Neoplasia
  • High Grade Vulvar Squamous Intraepithelial Lesion
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +1 more
Jan 24, 2023

HPV, Human Papilloma Virus, Human Immunodeficiency Virus Trial in Vancouver (Nonavalent HPV vaccine)

Not yet recruiting
  • HPV
  • +2 more
  • Nonavalent HPV vaccine
  • Vancouver, British Columbia, Canada
    University of British Columbia
Aug 8, 2022

HPV Vaccine, Provider Communication Practices, Vaccine Recommendation Practices Trial in Seattle (QI coaching intervention)

Completed
Has Results
  • HPV Vaccine
  • +2 more
  • QI coaching intervention
  • Seattle, Washington
    Kaiser Permanente Washington Health Research Institute
Jul 20, 2022

Warts, Human Papilloma Virus Trial in Zagazig (Candida antigen vaccine, Bivalent HPV vaccine)

Recruiting
  • Warts
  • Human Papilloma Virus
  • Candida antigen vaccine
  • Bivalent HPV vaccine
  • Zagazig, Al Sharqia, Egypt
    Reham Essam
Jul 26, 2022

Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papilloma Virus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Immunization, Efficacy, Human Papilloma Virus Trial in Galveston (9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3

Recruiting
  • Immunization
  • +2 more
  • 9-valent HPV vaccine, 2 dose efficacy
  • 9-valent HPV vaccine, 3 doses standard timing
  • Galveston, Texas
    University of Texas Medical Branch
Jan 30, 2023

Primary Prevention Trial in Aurora (Boot Camp Translation, Control)

Recruiting
  • Primary Prevention
  • Boot Camp Translation
  • Control
  • Aurora, Colorado
    University of Colorado Hospital
Jan 24, 2023

Human Papillomavirus Infection Trial in United States (Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant

Active, not recruiting
  • Human Papillomavirus Infection
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +5 more
Jan 26, 2023

HPV Infection Trial in H?i Phòng (Gardasil®, Merck)

Active, not recruiting
  • HPV Infection
  • Gardasil®, Merck
  • Hải Phòng, Vietnam
    Hai Phong District Health Centre
Sep 20, 2022

Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

Active, not recruiting
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
  • Guangzhou, Guangdong, China
  • +2 more
Dec 30, 2022

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Palmar or Plantar Warts Trial in Paris (Vaccination)

Recruiting
  • Palmar or Plantar Warts
  • Vaccination
  • Paris, France
    Hospital Cochin
Sep 6, 2022

Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)

Not yet recruiting
  • Human Papillomavirus Infection
  • Human papillomavirus (HPV) Vaccine
  • Placebo
  • Canberra, Australia
    Paratus Clinical Research Canberra
Jan 4, 2023

HPV Infection, HPV Vaccine Trial (HPV vaccine)

Not yet recruiting
  • HPV Infection
  • HPV Vaccine
  • HPV vaccine
  • (no location specified)
Mar 17, 2022